Tag: Lung Cancer

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Applied Spectral Imaging Announces Its GenASIs Applications Comply with CE-IVD Requirements with the IQFISH Lung Cancer Panel on Dako Omnis of Agilent Technologies Inc

| January 11, 2017 | 0 Comments

Carlsbad, CA – January 11, 2017 – Applied Spectral Imaging (ASI) announced today that its GenASIsTM  applications comply with CE-IVD requirements under the European Directive on In Vitro Diagnostic Medical Devices, for automated analysis with the IQFISH lung cancer panel on Dako Omnis (comprising of ALK, ROS1, RET and MET IQFISH probes) of Agilent Technologies […]

Continue Reading

A cancer patient and pathologist — brought together by Twitter — strike up an unlikely connection

| October 27, 2016 | 0 Comments

Courtesy of STAT  By Linnea Olson and Michael Misialek Awesome read about a patient and pathologist exploring lung cancer together. Patients can be their own best advocates while pathologists should have the opportunity to meet their patients. While every surgical pathology accession number is a life, putting a face with a name can be mutually beneficial. […]

Continue Reading

Webinar from PathXL: New Study on NSCLC Published – Register Now!

| August 23, 2015 | 0 Comments

Webinar: New Study on NSCLC published – Join the discussion The discovery and clinical application of molecular biomarkers in solid tumors, increasingly relies on nucleic acid extraction from FFPE tissue sections and subsequent molecular profiling. This, in turn, requires the pathological review of H&E stained slides, to ensure sample quality, tumor DNA sufficiency by visually estimating the […]

Continue Reading